Multiple sclerosis and related disordersHumansNeuromyelitis OpticaFemaleMaleAdult
Risk of hepatitis B and tuberculosis reactivation in patients with neuromyelitis optica spectrum disorder undergoing B cell depletion therapy.
Xi Wang, Shengfei Hu, Rui Hong, Xi Cheng, Ye Hong, Wei Qiu, Haotian Wu, Rui Li
Published: 202510.1016/j.msard.2025.106850
Abstract
INTRODUCTION: B cell-depleting agents are highly effective in preventing relapses in neuromyelitis optica spectrum disorder (NMOSD). Currently, no standardized guidelines exist for preventing hepatitis B reactivation (HBVr) or tuberculosis reactivati…
Preview only. Read the full abstract at the source